Abstract
In an earlier article, we demonstrated that sydnone SYD-1 (3-[4-chloro-3-nitrophenyl]-1,2,3-oxadiazolium-5-olate) inhibits electron transport in the respiratory chain and uncouples oxidative phosphorylation, and postulated that these effects are probably involved in its antitumor activity. We now report the effect of SYD-1 on certain macrophage functions, considering the important role of these cells in inflammatory response and also the relevant anti-inflammatory activity reported for some sydnones. Incubation of macrophages with SYD-1 (5–100 μM) for 48 h did not affect the cell viability up to a concentration of 50 μM. However, at the highest concentration (100 μM), the compound decreased macrophage viability by ~20%. In assays involving 2 h and 24 h of incubation, SYD-1 (5–100 μM) did not affect the cell viability. The incubation of macrophages with the compound for 2 h promoted a dose-dependent reduction of phagocytic activity of up to ~65% (100 μM). SYD-1 (100 μM) was also able to increase the production of superoxide anion (~50%). In the absence of LPS, SYD-1 decreased NO production dose-dependently by up to ~80% (100 μM). When SYD-1 and LPS were incubated concomitantly, the decrease of NO promoted by SYD was the most pronounced, reaching up to ~98% at the same concentration (50 μM). SYD-1 dose-dependently suppressed IL-6 secretion by LPS-stimulated macrophages, reaching up to ~90% of inhibition at the highest concentration (100 μM). These results indicate that SYD-1 promotes effects similar to those described for anti-inflammatory and immunosuppressive drugs, thus motivating further studies to clarify the mechanisms involved in this activity.
Similar content being viewed by others
References
Ollis WD, Ramsden CA (1976) Meso-ionic compounds. Adv Heterocycl Chem 19:1–121
Newton CG, Ramsden CA (1982) Meso-ionic heterocycles. Tetrahedron 38:2965–3011
Satyanarayana K, Rao MNA (1995) Synthesis and antiinflammatory, analgesic and antipyretic testing of 4-[1-oxo-(3-substituted aryl)-2-propenyl]-3-phenylsydnones and 3-[4-(3-(substituted aryl)-1-oxo-2-propenyl) phenyl] sydnones. J Pharm Sci 84:263–266
Cardoso JC, Cadena SMSC, Zamproio A, Arruda AMS, Carnieri EGS, Echevarria A, Constantin A, Bracht A, Oliveira MBM (2004) Effects of a new 1,3,4-thiadiazolium mesoionic compound, MI-D, on the acute inflammatory response. Drug Dev Res 61:207–217
Montanari CA, Beezer AE, Sandal JPB, Montanar MCL, Miller J, Giesbrecht AM (1992) On the interaction of some mesoionic compounds with Saccharomyces cerivisiae by biological microcalorimetry. Rev Microbiol 23:274–278
Corell T, Pedersen SB, Lissau B, Moilanen E, Metsä-Ketelä T, Kankaanranta H, Vuorinen P, Vapaatalo P, Rydell E, Andersson R, Marcinkiewicz E, Korbut R, Gryglewski RJ (1994) Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol J Pharm 46:553–566
Grynberg N, Gomes R, Shinzato T, Echevarria A, Miller J (1992) Some new aryl-sydnones: effects on murine tumours. Anticancer Res 12:1025–1028
Grynberg N, Santos AC, Echevarria A (1997) Synthesis and in vivo antitumor activity of new heterocyclic derivatives of the 1,3,4-thiadiazolium-2-aminide class. Anti-Cancer Drug 8:88–91
Senff-Ribeiro A, Echevarria A, Silva EF, Veiga SS, Oliveira MBM (2003) Effects of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on B16-F10 murine melanoma. Melanoma Res 13:465–472
Senff-Ribeiro A, Echevarria A, Silva EF, Veiga SS, Oliveira MBM (2004) Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure-activity relationship study. Anti-Cancer Drugs 15:269–275
Senff-Ribeiro A, Echevarria A, Silva EF, Veiga SS, Oliveira MBM (2004) Cytotoxic effect of a new 1,3,4-tiadiazolium mesoiônico compound (MI-D) on cell lines of human melanoma. Brit J Cancer 91:297–304
Moustafa MAA, Eisa HM (1992) Synthesis and antimicrobial activity of 3-(substituted-phenyl)—sydnones. Arch Pharm 325:397–401
Dunkley CS, Thoman CJ (2003) Synthesis and biological evaluation of a novel phenyl substituted sydnone series as potential antitumor agents. Bioorg Med Chem Lett 13:2899–2901
Halila GC, Oliveira MB, Echevarria A, Belém AC, Rocha ME, Carnieri EG, Martinez GR, Noleto GR, Cadena SM (2007) Effect of sydnone SYD-1, a mesoionic compound, on energy-linked functions of rat liver mitochondria. Chem Biol Interact 169(3):160–170
Bukke B, Lewis CE (2002) The macrophages. Oxford University Press, London
Akira S (2000) The role of IL-18 in innate immunity. Curr Opi Immunol 12:59–63
Sinigaglia F, D’ Ambrosio D, Panina-ordignon P, ordignon P, Rogge L (1997) Regulation of the IL-12/IL-12R axis: a critical step in T-help cell differentiation and effector function. Immunol Rev 170:65–72
Khanduja KL, Sohi KK, Pathak CM, Kaushik G (2006) Nimesulide inhibits lipopolysaccharide-induced production of superoxide anions and nitric oxide and iNOS expression in alveolar macrophages. Life Sci 78:1662–1669
Kishimoto T (2006) Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8:1–6
Min KR, Lee H, Kim BH, Chung E, Cho SM, Kim Y (2005) Inhibitory effect of 6-hydroxy-7-methoxychroman-2-carboxylic acid phenylamide on nitric oxide and interleukin-6 production in macrophages. Life Sci 77:3247–3257
Klimp AH, de Vries EG, Scherphof GL, Daemen T (2002) A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol 44(2):143–161
Verma N, Tripathi SK, Sahu D, Das HR, Das RH (2010) Evaluation of inhibitory activities of plant extracts on production of LPS-stimulated pro-inflammatory mediators in J774 murine macrophages. Mol Cell Biochem 336:127–135
Wagner H, Hill JB (1974) Anti-inflammatory sydnones. 1. J Med Chem 17(12):1337–1338
Hill JB, Ray RE, Wagner H, Aspinall R (1975) Antiinflammatory sydnones. 2. J Med Chem 18(1):50–53
Satyanarayana K, Rao MNA (1995) Synthesis of 4-[5-(substituted aryl)-4,5-dihydro-1H-pyrazol-3-yl]-3-phenyl-sydnones as anti-inflammatory, antiarthritic and analgesic agents. Eur J Med Chem 30:641–645
Sasada M, Pabt MJ, Johnston JRB (1983) Activation of mouse peritoneal macrophages by lipopolysaccharide alters the kinetic parameters of the superoxide-producing NADPH oxidase. J Biol Chem 258(16):9631–9635
Reilly TP, Belleveue FHIII, Worster PM, Svesson CK (1998) Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone. Biochem Pharmacol 55:803–808
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N nitrates] in biological fluids. Anal Biochem 126:131–138
Ramesh HP, Yamaki K, Tsushida T (2002) Effects of fenugreek (Trigonella foenum-graecum L.) galactomannan fractions on phagocytosis in rat macrophages and on proliferation and IgM secretion in HB4C5 cells. Carbohyd Polym 50:79–83
Buchi DF, Souza W (1993) Internalization of surface components during Fc-receptor mediated phagocytosis. Cell Struct Funct 18:399–407
Bradford M (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Mosser DM (2003) The many faces of macrophages activation. J Leukocyte Biol 73:209–212
Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H (2003) Molecular mechanisms of macrophages activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Therapeut 100:171–194
Cho JY (2007) Immmunomodulatory Effect of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) at clinically available doses. Arch Pharm Res 30(1):64–74
Long F, wang Y-X, Liu L, Zhou J, Cui R-Y, Jiang C-L (2005) Rapid nongenomic inhibitory effects of glucocorticoids on phagocytosis and superoxide anion production by nacrophages. Steroids 70:55–61
Attur MG, Patel R, Thakker G, Vyas P, levartovsky D, Patel P, Naqvi S, Raza R, Patel K, Abramson D, Bruno G, Abramson SB, Amin AR (2000) Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production. Inflamm Res 49:020–026
Petronilli V, Nicolli A, Costantini A, Colonna R (1994) Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim Biophys Acta 1187:255–259
Kim J, He L, Lemasters JJ (2003) Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 304:463–470
Shin H-M, Lee YR, Chang YS, Lee J-Y, Kim BH, Min KR, Kim Y (2006) Suppression of interleukin-6 production in macrophages by furonaphthoquinone NFD-37. Int Immunopharmacol 6:916–923
Acknowledgments
This investigation was supported by the Brazilian research funding agencies CNPq and CAPES.
Author information
Authors and Affiliations
Corresponding author
Additional information
E. L. Bizetto and G. R. Noleto contributed equally to this study.
Rights and permissions
About this article
Cite this article
Bizetto, E.L., Noleto, G.R., Echevarria, A. et al. Effect of sydnone SYD-1 on certain functions of LPS-stimulated macrophages. Mol Cell Biochem 360, 15–21 (2012). https://doi.org/10.1007/s11010-011-1038-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-011-1038-4